We constructed HDAds encoding either inducible T cell costimulator ligand (ICOSL), OX40L, or 41BBL, for which agonistic antibodies have been tested in clinical trials [42,43], and confirmed cancer cell surface expression of these molecules after infection (Figure 2D). This evidence concerns the gene TNFSF4 and cancer.